HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain. - Wikidata - wikimedia - TriplyDB

HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain.

HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain.

http://www.wikidata.org/entity/Q37439341

about

Changing channels in pain and epilepsy: Exploiting ion channel gene therapy for disorders of neuronal hyperexcitability Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS Gene delivery with viral vectors for cerebrovascular diseases.Advances in Gene Delivery Systems.An HSV-based library screen identifies PP1α as a negative TRPV1 regulator with analgesic activity in models of pain Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in Rats Selective targeting of ASIC3 using artificial miRNAs inhibits primary and secondary hyperalgesia after muscle inflammation The fundamental unit of pain is the cell.HSV Recombinant Vectors for Gene Therapy.Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications Herpes simplex virus-based nerve targeting gene therapy in pain management.Low GRK2 Underlies Hyperalgesic Priming by Glial Cell-Derived Neurotrophic Factor.A bright future? Optogenetics in the periphery for pain research and therapy

P2860

Q28081164-5921DD4C-612F-46F4-87B3-A59CA468891E Q33894621-CBC98FDF-0CAD-40D9-8FB4-E17F6EBD391E Q33917592-174BF304-BB9C-4C8D-9539-CB06D4221D81 Q35632772-D49935F7-F401-4777-B55B-3206CA6A8896 Q36068723-4A7221D4-F33C-41A2-94CA-2FE76470F1C2 Q36294712-48B3A520-CF6D-4015-B52E-3B4CCDBB4494 Q36334054-B56E243A-5F92-4934-A53C-9A6C76F1B886 Q37381403-D4B192B1-3761-45CD-A7D8-E911166D3ED7 Q37787777-512C7481-52A7-4C86-85FA-CC5A39E8DCB5 Q38166648-DB049673-E8AC-4DB4-8C38-5058ACAB9E9C Q38182564-D9B9143A-FFCB-4AB9-BCDE-193D9E6821F1 Q55248528-2EA2D384-AB99-4A04-9AB9-0CF59720F680 Q57165754-AD4F5A69-639E-46A5-AA3C-EF348F826FC8

P2860

HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain.

http://www.wikidata.org/entity/Q37439341

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HSV vector-mediated modificati ...... roach to inhibit chronic pain.

@en

HSV vector-mediated modificati ...... roach to inhibit chronic pain.

@nl

type

label

HSV vector-mediated modificati ...... roach to inhibit chronic pain.

@en

HSV vector-mediated modificati ...... roach to inhibit chronic pain.

@nl

prefLabel

HSV vector-mediated modificati ...... roach to inhibit chronic pain.

@en

HSV vector-mediated modificati ...... roach to inhibit chronic pain.

@nl

P1433

Q37439341-5135D740-0D73-4B70-9C7E-AD078003E0E4

P1476

Q37439341-CD8C32CB-70BC-43FC-BB85-96E20D3A7784

P2093

Q37439341-6B1C6F11-764E-412D-A556-C18FF1CBC83C

Q37439341-C7F412CE-84E5-4192-9359-E85FBCD0DB66

Q37439341-D1387437-D379-45DC-BD26-544A15B759EB

P2860

Q37439341-05C9DD18-F532-4F97-93FA-EF044C1CF480

Q37439341-0628AAFD-BE8D-4788-B186-BB8574D3FB2A

Q37439341-09D17061-7E35-4AB6-8E9B-53C0883F111D

Q37439341-154E01B8-02B1-4F93-9CF8-927BC5DE13F9

Q37439341-18632C62-557D-4E41-BD24-FBCEAF960AD4

Q37439341-1AF2C716-815E-4D12-9948-6DB6357CE005

Q37439341-1ECB5859-8E46-409B-9371-7975D84B0DA0

Q37439341-2A73F501-C2E2-4805-A7B6-5C333AF07766

Q37439341-2ACC3998-3D48-4378-A390-EB03F0A31076

Q37439341-2B27989C-73D1-4850-8682-C27FE24F8026

P2888

Q37439341-0B7DA175-CB2F-4572-9220-27E59CF65A0D

P304

Q37439341-A1DBC4B1-5F2C-4F63-ACB3-648B406AC1A1

P31

Q37439341-C85FFECA-CA44-4635-894B-694C63129B78

P356

Q37439341-AA5EE5E3-07FA-4885-BA01-A1163364D9AF

P433

Q37439341-3FB49A44-F9A2-4011-9600-3A9839B4A4EB

P478

Q37439341-90A471B9-D637-49AF-A54D-C991F641F801

P577

Q37439341-364218D8-BD4F-4202-B08F-BF73F4143A9C

P5875

Q37439341-BFB875BB-88EA-425D-A932-E27098FA2CEF

P698

Q37439341-C970F638-C61D-471D-96A1-5563DABA1302

P921

Q37439341-0f42afe7-b0d1-4198-8534-72c304ca962a

Q37439341-C549A9B3-D7D5-4F29-AC83-C253C60D2702

P932

Q37439341-69D4C394-D26B-4A70-8C39-DE8F78973224

P356

P1433

P1476

HSV vector-mediated modificati ...... roach to inhibit chronic pain.

@en

P2093

J C Glorioso

http://www.w3.org/2001/XMLSchema#string

J R Goss

http://www.w3.org/2001/XMLSchema#string

M S Gold

http://www.w3.org/2001/XMLSchema#string

P2860

An SCN9A channelopathy causes congenital inability to experience pain

Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10

Encoding of burning pain from capsaicin-treated human skin in two categories of unmyelinated nerve fibres

Clinical Effectiveness and Cost-Effectiveness of Treatments for Patients With Chronic Pain

An HSV vector system for selection of ligand-gated ion channel modulators.

Engineering herpes simplex virus vectors for CNS applications.

Characterization of a recombinant herpes simplex virus 1 designed to enter cells via the IL13Ralpha2 receptor of malignant glioma cells.

HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

P2888

P304

493-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2009.24

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24267802

http://www.w3.org/2001/XMLSchema#string

P698

19357694

http://www.w3.org/2001/XMLSchema#string

P921

chronic primary pain

P932

3426358

http://www.w3.org/2001/XMLSchema#string